Medifast (MED) Cash from Investing Activities (2010 - 2026)

Medifast (MED) has 17 years of Cash from Investing Activities data on file, last reported at -$17.1 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 734.13% year-over-year to -$17.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.0 million (up 10.82% YoY) and the FY2025 annual result came in at -$7.9 million, up 70.11% from the prior year.
• Cash from Investing Activities retreated to -$17.1 million in Q1 2026, from -$5.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $13.4 million in Q2 2025 to a low of -$46.5 million in Q3 2023.
• A 5-year average of -$7.3 million and a median of -$2.5 million in 2024 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities plunged 2527.66% — and 2025, when it jumped 627.53%.
• Tracing MED's Cash from Investing Activities over 5 years: stood at -$9.1 million in 2022, then retreated by 18.39% to -$10.7 million in 2023, then tumbled by 81.07% to -$19.4 million in 2024, then jumped by 74.53% to -$5.0 million in 2025, then sank by 246.12% to -$17.1 million in 2026.
• The last three Cash from Investing Activities figures came in at -$17.1 million (Q1 2026), -$5.0 million (Q4 2025), and -$14.3 million (Q3 2025), per Business Quant data.